Literature DB >> 2882341

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.

P T Donaldson, G J Alexander, J O'Grady, J Neuberger, B Portmann, M Thick, H Davis, R Y Calne, R Williams.   

Abstract

The relation between donor and recipient status for HLA class I and II antigens in 62 patients undergoing liver transplantation was examined with particular reference to a well-defined variant of chronic rejection, the vanishing-bileduct (VBD) syndrome. A complete mismatch for class I antigens was more common in those with the VBD syndrome than in those with normal graft function or chronic graft malfunction unrelated to the syndrome (p less than 0.025). In contrast, a complete mismatch for class II antigens was considerably less common in those with the VBD syndrome than in those without (p less than 0.02). The association of a complete mismatch for class I and a partial or complete match for class II antigens with the VBD syndrome was highly significant (p less than 0.0005). These findings support the hypothesis that in the VBD syndrome both class I antigen expression on bileduct epithelium and immunological interaction at the level of class II antigens are required for the rejection process to occur. In addition, high-titre donor-specific antibodies to class I antigen, which were present in 6 of 14 of those with the VBD syndrome but in none of those without (p less than 0.0005), may be involved in the pathogenesis of bileduct damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882341     DOI: 10.1016/s0140-6736(87)90293-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

1.  HLA matching and the point system.

Authors:  Thomas E Starzl; Anthony J Demetris; Massimo Trucco
Journal:  Clin Transplant       Date:  1993       Impact factor: 2.863

2.  Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Authors:  S L Saidman; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl; A J Demetris
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

Review 3.  Liver transplantation.

Authors:  J G O'Grady; B Portmann
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.

Authors:  R Mañez; L T White; S Kusne; M Martin; A J Demetris; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Establishment of Primary Cultures of Human Biliary Epithelium and Induction of Class II Major Histocompatibility Complex Antigens by Interferon Gamma.

Authors:  A J Demetris; B Markus; S Saidman; J Fung; L Makowka; R Duquesnoy; T E Starzl
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

6.  Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch.

Authors:  H R Doyle; I R Marino; F Morelli; C Doria; L Aldrighetti; J McMichael; J Martell; T Gayowski; T E Starzl
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

7.  The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation.

Authors:  A I Musat; R M Agni; P Y Wai; J D Pirsch; D F Lorentzen; A Powell; G E Leverson; J M Bellingham; L A Fernandez; D P Foley; J D Mezrich; A M D'Alessandro; M R Lucey
Journal:  Am J Transplant       Date:  2011-03       Impact factor: 8.086

Review 8.  Present position of liver transplantation and its impact on hepatological practice.

Authors:  J G O'Grady; R Williams
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

9.  Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings.

Authors:  B H Markus; A J Demetris; J J Fung; S Saidman; A Zeevi; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

10.  Global analysis of differential expressed genes in ECV304 Endothelial-like cells infected with human cytomegalovirus.

Authors:  Mo Xiaoyang; Z Haiquan; Z Huanying; K Changwen; Z Wenling; Tu Yanyang; Z Yongsheng
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.